The pulmonary mucus of cystic fibrosis (CF) patients displays elevated levels of the cathelicidin antimicrobial peptide LL-37 and the aim of this work was to assess the effect of LL-37 on the growth of , a common pathogen of CF patients. Exposure of to LL-37 and its derived fragment RK-31 (1.95 μg/ml) for 24 hours had a positive effect on growth (199.94 ± 6.172%, p < 0.05) and (218.20 ± 4.63%, p < 0.05) respectively, whereas scrambled LL-37 peptide did not (85.12 ± 2.92%). Exposure of 24 hour pre-formed mycelium to 5 μg/ml intact LL-37 for 48 hours increased hyphal wet weight (4.37 ± 0.23 g, p < 0.001) compared to the control (2.67 ± 0.05 g) and scrambled LL-37 (2.23 ± 0.09 g) treatments. Gliotoxin secretion was increased at 24 hours from LL-37 exposed hyphae (169.1 ± 6.36 ng/mg hyphae, p < 0.05) compared to the control (102 ± 18.81 ng/mg hyphae) and scrambled LL-37 (96.09 ± 15.15 ng/mg hyphae) treatments. Shotgun proteomic analysis of 24 hour LL-37 treated hyphae revealed an increase in the abundance of proteins associated with growth (eIF-5A (16.3 fold increased), tissue degradation (aspartic endopeptidase (4.7 fold increased)) and allergic reactions (Asp F13 (10 fold increased)). By 48 hour there was an increase in proteins indicative of cellular stress (glutathione peroxidase (9 fold increased)), growth (eIF-5A (6 fold increased)), and virulence (ribonuclease mitogillin (3.7 fold increased)). These results indicate that LL-37 stimulates growth and this may result in increased fungal growth and secretion of toxins in the lungs of CF patients.